-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medtronic announced its fourth-quarter and full-year fiscal 2021 results
.
The total revenue for the year was 30.
117 billion U.
S.
dollars and the net profit was 3.
606 billion U.
S.
dollars
.
In the fourth quarter, total revenue was 8.
188 billion U.
S.
dollars and net profit was 1.
361 billion U.
S.
dollars
.
.
The total revenue for the year was 30.
117 billion U.
S.
dollars and the net profit was 3.
606 billion U.
S.
dollars
.
In the fourth quarter, total revenue was 8.
188 billion U.
S.
dollars and net profit was 1.
361 billion U.
S.
dollars
.
Thermo Fisher Scientific announced its first quarter 2021 results
.
Quarterly revenue was 9.
906 billion U.
S.
dollars, compared with 6.
23 billion U.
S.
dollars in the same period last year
.
Net profit for the quarter was US$2.
337 billion, compared with US$788 million in the same period last year
.
Among them, the life science business income was US$4.
203 billion, compared with US$1.
774 billion in the same period last year
.
Revenue from laboratory products and services was US$3.
597 billion, compared with US$2.
73 billion in the same period last year
.
Professional diagnostics business revenue was 1.
615 billion U.
S.
dollars, compared with 958 million U.
S.
dollars in the same period last year
.
Analytical instrument revenue was 1.
387 billion U.
S.
dollars, compared with 1.
101 billion U.
S.
dollars in the same period last year
.
.
Quarterly revenue was 9.
906 billion U.
S.
dollars, compared with 6.
23 billion U.
S.
dollars in the same period last year
.
Net profit for the quarter was US$2.
337 billion, compared with US$788 million in the same period last year
.
Among them, the life science business income was US$4.
203 billion, compared with US$1.
774 billion in the same period last year
.
Revenue from laboratory products and services was US$3.
597 billion, compared with US$2.
73 billion in the same period last year
.
Professional diagnostics business revenue was 1.
615 billion U.
S.
dollars, compared with 958 million U.
S.
dollars in the same period last year
.
Analytical instrument revenue was 1.
387 billion U.
S.
dollars, compared with 1.
101 billion U.
S.
dollars in the same period last year
.
Abbott (Abbott) announced the first quarter of 2021 results
.
Quarterly net sales were US$10.
456 billion, a year-on-year increase of 35.
3%; net profit was US$1.
793 billion, a year-on-year increase of 217.
8%
.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%
.
.
Quarterly net sales were US$10.
456 billion, a year-on-year increase of 35.
3%; net profit was US$1.
793 billion, a year-on-year increase of 217.
8%
.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%
.
Fresenius SE & Co.
KGaA announced the results for the first quarter of 2021
.
Sales in the quarter were 8.
984 billion euros (approximately 10.
9 billion US dollars), compared with 9.
135 billion euros in the same period last year
.
Operating profit for the quarter was 1.
006 billion euros, compared with 1.
125 billion euros in the same period last year
.
Net profit for the quarter was 671 million euros, compared with 730 million euros in the same period last year
.
Among them, the sales of Fresenius medical business were 4.
21 billion euros, the sales of Fresenius Kabi business were 1.
761 billion euros, the sales of Fresenius Helios clinic business was 2.
649 billion euros, and the sales of Fresenius Omed Amount of 477 million euros
.
KGaA announced the results for the first quarter of 2021
.
Sales in the quarter were 8.
984 billion euros (approximately 10.
9 billion US dollars), compared with 9.
135 billion euros in the same period last year
.
Operating profit for the quarter was 1.
006 billion euros, compared with 1.
125 billion euros in the same period last year
.
Net profit for the quarter was 671 million euros, compared with 730 million euros in the same period last year
.
Among them, the sales of Fresenius medical business were 4.
21 billion euros, the sales of Fresenius Kabi business were 1.
761 billion euros, the sales of Fresenius Helios clinic business was 2.
649 billion euros, and the sales of Fresenius Omed Amount of 477 million euros
.
Danaher Group (Danaher) announced the first quarter of 2021 results
.
Net income was US$1.
7 billion
.
Revenue increased by 58.
0% year-on-year to US$6.
9 billion, of which non-GAAP core revenue, including Cytiva, increased by 30.
0%
.
.
Net income was US$1.
7 billion
.
Revenue increased by 58.
0% year-on-year to US$6.
9 billion, of which non-GAAP core revenue, including Cytiva, increased by 30.
0%
.
Johnson & Johnson (Johnson & Johnson) announced the first quarter of 2021 results
.
Quarterly sales were US$22.
321 billion, an increase of 7.
9% year-on-year; net profit was US$6.
197 billion, an increase of 6.
9% year-on-year
.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million
.
Medical device business sales were US$6.
579 billion, a year-on-year increase of 10.
9%
.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%
.
.
Quarterly sales were US$22.
321 billion, an increase of 7.
9% year-on-year; net profit was US$6.
197 billion, an increase of 6.
9% year-on-year
.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million
.
Medical device business sales were US$6.
579 billion, a year-on-year increase of 10.
9%
.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%
.
BD announced its first quarter 2021 results
.
Quarterly revenue was US$4.
907 billion, an increase of 15.
4% from US$4.
253 billion in the same period last year; net profit was US$277 million, an increase of 90.
6% from US$145 million in the same period last year
.
.
Quarterly revenue was US$4.
907 billion, an increase of 15.
4% from US$4.
253 billion in the same period last year; net profit was US$277 million, an increase of 90.
6% from US$145 million in the same period last year
.
Siemens Healthineers (Siemens Healthineers) announced its results for the second quarter of fiscal year 2021 as of March 31
.
Quarterly revenue was 3.
965 billion euros (approximately US$4.
83 billion), compared with 3.
685 billion euros in the same period last year
.
Adjusted EBIT profit was 666 million euros, compared with 665 million euros in the same period last year
.
Net profit for the quarter was 447 million euros, compared with 414 million euros in the same period last year
.
.
Quarterly revenue was 3.
965 billion euros (approximately US$4.
83 billion), compared with 3.
685 billion euros in the same period last year
.
Adjusted EBIT profit was 666 million euros, compared with 665 million euros in the same period last year
.
Net profit for the quarter was 447 million euros, compared with 414 million euros in the same period last year
.
Roche announced its first quarter 2021 results
.
Group sales in the quarter were 14.
9 billion Swiss francs, compared with 15.
1 billion Swiss francs in the same period last year
.
Among them, sales in the pharmaceuticals department were 10.
6 billion Swiss francs, a year-on-year decrease of 14%; sales in the diagnostics department were 4.
3 billion Swiss francs (approximately US$4.
765 billion), a year-on-year increase of 50%
.
.
Group sales in the quarter were 14.
9 billion Swiss francs, compared with 15.
1 billion Swiss francs in the same period last year
.
Among them, sales in the pharmaceuticals department were 10.
6 billion Swiss francs, a year-on-year decrease of 14%; sales in the diagnostics department were 4.
3 billion Swiss francs (approximately US$4.
765 billion), a year-on-year increase of 50%
.
The financial report released by Philips shows that in the first quarter of 2021, sales were 3.
827 billion euros (approximately 4.
66 billion US dollars), an increase of 3.
6% year-on-year; net profit was 40 million euros, compared with 39 million euros in the same period last year
.
It has allocated 250 million euros to deal with risks related to quality problems detected in some of its respiratory health care equipment
.
In the first quarter, adjusted profit before interest, taxes and amortization (EBITA) soared 74% year-on-year to 362 million euros.
Comparable sales increased by 9%, far exceeding market expectations, as the new crown epidemic promoted its hospital equipment and The demand for personal health appliances
.
827 billion euros (approximately 4.
66 billion US dollars), an increase of 3.
6% year-on-year; net profit was 40 million euros, compared with 39 million euros in the same period last year
.
It has allocated 250 million euros to deal with risks related to quality problems detected in some of its respiratory health care equipment
.
In the first quarter, adjusted profit before interest, taxes and amortization (EBITA) soared 74% year-on-year to 362 million euros.
Comparable sales increased by 9%, far exceeding market expectations, as the new crown epidemic promoted its hospital equipment and The demand for personal health appliances
.
General Electric (GE) announced the first quarter of 2021 financial results
.
Quarterly revenue was 17.
118 billion U.
S.
dollars, compared with 19.
49 billion U.
S.
dollars in the same period last year
.
The quarterly net loss was US$2.
798 billion, and a net profit of US$6.
233 billion was recorded in the same period last year
.
The revenue of the industrial sector was US$16.
329 billion, a year-on-year decrease of 13%; the revenue of the capital sector was US$878 million, a year-on-year increase of 5%
.
Divided by specific business, medical business revenue was US$4.
309 billion, a year-on-year decrease of 9%
.
.
Quarterly revenue was 17.
118 billion U.
S.
dollars, compared with 19.
49 billion U.
S.
dollars in the same period last year
.
The quarterly net loss was US$2.
798 billion, and a net profit of US$6.
233 billion was recorded in the same period last year
.
The revenue of the industrial sector was US$16.
329 billion, a year-on-year decrease of 13%; the revenue of the capital sector was US$878 million, a year-on-year increase of 5%
.
Divided by specific business, medical business revenue was US$4.
309 billion, a year-on-year decrease of 9%
.
Stryker, a medical device and equipment manufacturer, announced its first quarter 2021 results
.
Quarterly net sales were US$3.
953 billion, an increase of 10.
2% from US$3.
588 billion in the same period last year; net profit was US$302 million, a decrease of 38.
7% from US$493 million in the same period last year
.
.
Quarterly net sales were US$3.
953 billion, an increase of 10.
2% from US$3.
588 billion in the same period last year; net profit was US$302 million, a decrease of 38.
7% from US$493 million in the same period last year
.
Baxter International Inc.
announced its first quarter 2021 results
.
Quarterly net sales were US$2.
946 billion, an increase of 5% from US$2.
802 billion in the same period last year; net profit was US$298 million, a decrease of 10% from US$332 million in the same period last year
.
announced its first quarter 2021 results
.
Quarterly net sales were US$2.
946 billion, an increase of 5% from US$2.
802 billion in the same period last year; net profit was US$298 million, a decrease of 10% from US$332 million in the same period last year
.
Henry Schein announced its first quarter 2021 results
.
Quarterly net sales were US$2.
925 billion, compared with US$2.
429 billion in the same period last year; net profit was US$166 million, compared with US$130 million in the same period last year
.
.
Quarterly net sales were US$2.
925 billion, compared with US$2.
429 billion in the same period last year; net profit was US$166 million, compared with US$130 million in the same period last year
.
Boston Scientific announced its first quarter 2021 results
.
Quarterly net sales were US$2.
752 billion, compared with US$2.
543 billion in the same period last year; net profit was US$327 million, compared with US$11 million in the same period last year
.
.
Quarterly net sales were US$2.
752 billion, compared with US$2.
543 billion in the same period last year; net profit was US$327 million, compared with US$11 million in the same period last year
.
Owens & Minor (Owens & Minor) announced the first quarter of 2021 results
.
Quarterly revenue was US$2.
327 billion, compared with US$2.
123 billion in the same period of the previous year; net profit was US$69.
59 million, and a net loss of US$11.
32 million in the same period last year
.
.
Quarterly revenue was US$2.
327 billion, compared with US$2.
123 billion in the same period of the previous year; net profit was US$69.
59 million, and a net loss of US$11.
32 million in the same period last year
.
3M Company announced the first quarter of 2021 results
.
Quarterly net sales of 8.
851 billion U.
S.
dollars, compared with 8.
075 billion U.
S.
dollars in the same period last year
.
The quarterly net profit was 1.
624 billion U.
S.
dollars, compared with 1.
308 billion U.
S.
dollars in the same period last year
.
Among them, the total sales of health care products are 2.
248 billion US dollars
.
.
Quarterly net sales of 8.
851 billion U.
S.
dollars, compared with 8.
075 billion U.
S.
dollars in the same period last year
.
The quarterly net profit was 1.
624 billion U.
S.
dollars, compared with 1.
308 billion U.
S.
dollars in the same period last year
.
Among them, the total sales of health care products are 2.
248 billion US dollars
.
Alcon (Alcon) announced the first quarter of 2021 results
.
Quarterly revenue was US$1.
93 billion, compared with US$1.
841 billion in the same period last year; net profit was US$84 million and a net loss of US$57 million in the same period last year
.
.
Quarterly revenue was US$1.
93 billion, compared with US$1.
841 billion in the same period last year; net profit was US$84 million and a net loss of US$57 million in the same period last year
.
Zimmer Biomet Holdings Inc.
announced its first quarter 2021 results
.
Quarterly net sales were US$1.
847 billion, compared to US$1.
784 billion in the same period last year; net profit was US$198 million and a net loss of US$508 million in the same period last year
.
announced its first quarter 2021 results
.
Quarterly net sales were US$1.
847 billion, compared to US$1.
784 billion in the same period last year; net profit was US$198 million and a net loss of US$508 million in the same period last year
.
Olympus (OLYMPUS) announced its fiscal year results (April 2020-March 2021)
.
Revenue in the fiscal year was 730.
5 billion yen (approximately US$6.
645 billion), compared with 755.
2 billion yen in the previous year
.
Operating profit for the fiscal year was 81.
985 billion yen, compared with 92.
2 billion yen in the previous fiscal year
.
Net profit for the fiscal year was 12.
918 billion yen, compared with 51.
67 billion yen in the previous fiscal year
.
Among them, the endoscope business revenue was 425.
742 billion yen, the treatment business revenue was 21.
075 billion yen, and the scientific business revenue was 105.
189 billion yen
.
.
Revenue in the fiscal year was 730.
5 billion yen (approximately US$6.
645 billion), compared with 755.
2 billion yen in the previous year
.
Operating profit for the fiscal year was 81.
985 billion yen, compared with 92.
2 billion yen in the previous fiscal year
.
Net profit for the fiscal year was 12.
918 billion yen, compared with 51.
67 billion yen in the previous fiscal year
.
Among them, the endoscope business revenue was 425.
742 billion yen, the treatment business revenue was 21.
075 billion yen, and the scientific business revenue was 105.
189 billion yen
.
Terumo announced its fiscal year results (April 2020-March 2021)
.
Fiscal year revenue was 613.
8 billion yen (approximately US$5.
583 billion), compared with 628.
9 billion yen in the previous year
.
Operating profit for the fiscal year was 98.
386 billion yen, compared with 110.
611 billion yen in the previous fiscal year
.
The net profit for the fiscal year was 77.
268 billion yen, compared with 85.
211 billion yen in the previous fiscal year
.
.
Fiscal year revenue was 613.
8 billion yen (approximately US$5.
583 billion), compared with 628.
9 billion yen in the previous year
.
Operating profit for the fiscal year was 98.
386 billion yen, compared with 110.
611 billion yen in the previous fiscal year
.
The net profit for the fiscal year was 77.
268 billion yen, compared with 85.
211 billion yen in the previous fiscal year
.
Smith & Nephew (Smith & Nephew) announced the first quarter of 2021 results
.
The quarterly total revenue was US$1.
264 billion, an increase of 11.
5% from US$1.
134 billion in the same period last year
.
.
The quarterly total revenue was US$1.
264 billion, an increase of 11.
5% from US$1.
134 billion in the same period last year
.
Canon Group (Canon) released its financial report for the first quarter of 2021
.
Group turnover increased by 7.
7% year-on-year to 842.
7 billion yen
.
The group's net profit was 44.
454 billion yen, a year-on-year increase of 102.
9%
.
Among them, the turnover of the medical business this quarter increased by 17.
3% compared with the same period last year, to 124.
4 billion yen (approximately 1.
13 billion US dollars)
.
.
Group turnover increased by 7.
7% year-on-year to 842.
7 billion yen
.
The group's net profit was 44.
454 billion yen, a year-on-year increase of 102.
9%
.
Among them, the turnover of the medical business this quarter increased by 17.
3% compared with the same period last year, to 124.
4 billion yen (approximately 1.
13 billion US dollars)
.
Mindray Medical released its first quarterly report for 2021.
The company achieved revenue of 5.
781 billion yuan (approximately US$906 million), a year-on-year increase of 21.
93%, and achieved a net profit of 1.
715 billion yuan attributable to the parent, a year-on-year increase of 30.
59%
.
( Global Corporate News )
The company achieved revenue of 5.
781 billion yuan (approximately US$906 million), a year-on-year increase of 21.
93%, and achieved a net profit of 1.
715 billion yuan attributable to the parent, a year-on-year increase of 30.
59%
.
( Global Corporate News )
Medtronic announced its fourth-quarter and full-year fiscal 2021 results
.
The total revenue for the year was 30.
117 billion U.
S.
dollars and the net profit was 3.
606 billion U.
S.
dollars
.
In the fourth quarter, total revenue was 8.
188 billion U.
S.
dollars and net profit was 1.
361 billion U.
S.
dollars
.
.
The total revenue for the year was 30.
117 billion U.
S.
dollars and the net profit was 3.
606 billion U.
S.
dollars
.
In the fourth quarter, total revenue was 8.
188 billion U.
S.
dollars and net profit was 1.
361 billion U.
S.
dollars
.
Thermo Fisher Scientific announced its first quarter 2021 results
.
Quarterly revenue was 9.
906 billion U.
S.
dollars, compared with 6.
23 billion U.
S.
dollars in the same period last year
.
Net profit for the quarter was US$2.
337 billion, compared with US$788 million in the same period last year
.
Among them, the life science business income was US$4.
203 billion, compared with US$1.
774 billion in the same period last year
.
Revenue from laboratory products and services was US$3.
597 billion, compared with US$2.
73 billion in the same period last year
.
Professional diagnostics business revenue was 1.
615 billion U.
S.
dollars, compared with 958 million U.
S.
dollars in the same period last year
.
Analytical instrument revenue was 1.
387 billion U.
S.
dollars, compared with 1.
101 billion U.
S.
dollars in the same period last year
.
.
Quarterly revenue was 9.
906 billion U.
S.
dollars, compared with 6.
23 billion U.
S.
dollars in the same period last year
.
Net profit for the quarter was US$2.
337 billion, compared with US$788 million in the same period last year
.
Among them, the life science business income was US$4.
203 billion, compared with US$1.
774 billion in the same period last year
.
Revenue from laboratory products and services was US$3.
597 billion, compared with US$2.
73 billion in the same period last year
.
Professional diagnostics business revenue was 1.
615 billion U.
S.
dollars, compared with 958 million U.
S.
dollars in the same period last year
.
Analytical instrument revenue was 1.
387 billion U.
S.
dollars, compared with 1.
101 billion U.
S.
dollars in the same period last year
.
Abbott (Abbott) announced the first quarter of 2021 results
.
Quarterly net sales were US$10.
456 billion, a year-on-year increase of 35.
3%; net profit was US$1.
793 billion, a year-on-year increase of 217.
8%
.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%
.
.
Quarterly net sales were US$10.
456 billion, a year-on-year increase of 35.
3%; net profit was US$1.
793 billion, a year-on-year increase of 217.
8%
.
By business, the nutrition business sales were US$2.
036 billion, a year-on-year increase of 6.
9%; the diagnostic business sales were US$4.
014 billion, a year-on-year increase of 119.
8%; the pharmaceutical business sales were US$1.
070 billion, a year-on-year increase of 2.
5%; and the medical device business sales The amount was US$3.
320 billion, a year-on-year increase of 13.
1%
.
Fresenius SE & Co.
KGaA announced the results for the first quarter of 2021
.
Sales in the quarter were 8.
984 billion euros (approximately 10.
9 billion US dollars), compared with 9.
135 billion euros in the same period last year
.
Operating profit for the quarter was 1.
006 billion euros, compared with 1.
125 billion euros in the same period last year
.
Net profit for the quarter was 671 million euros, compared with 730 million euros in the same period last year
.
Among them, the sales of Fresenius medical business were 4.
21 billion euros, the sales of Fresenius Kabi business were 1.
761 billion euros, the sales of Fresenius Helios clinic business was 2.
649 billion euros, and the sales of Fresenius Omed Amount of 477 million euros
.
KGaA announced the results for the first quarter of 2021
.
Sales in the quarter were 8.
984 billion euros (approximately 10.
9 billion US dollars), compared with 9.
135 billion euros in the same period last year
.
Operating profit for the quarter was 1.
006 billion euros, compared with 1.
125 billion euros in the same period last year
.
Net profit for the quarter was 671 million euros, compared with 730 million euros in the same period last year
.
Among them, the sales of Fresenius medical business were 4.
21 billion euros, the sales of Fresenius Kabi business were 1.
761 billion euros, the sales of Fresenius Helios clinic business was 2.
649 billion euros, and the sales of Fresenius Omed Amount of 477 million euros
.
Danaher Group (Danaher) announced the first quarter of 2021 results
.
Net income was US$1.
7 billion
.
Revenue increased by 58.
0% year-on-year to US$6.
9 billion, of which non-GAAP core revenue, including Cytiva, increased by 30.
0%
.
.
Net income was US$1.
7 billion
.
Revenue increased by 58.
0% year-on-year to US$6.
9 billion, of which non-GAAP core revenue, including Cytiva, increased by 30.
0%
.
Johnson & Johnson (Johnson & Johnson) announced the first quarter of 2021 results
.
Quarterly sales were US$22.
321 billion, an increase of 7.
9% year-on-year; net profit was US$6.
197 billion, an increase of 6.
9% year-on-year
.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million
.
Medical device business sales were US$6.
579 billion, a year-on-year increase of 10.
9%
.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%
.
.
Quarterly sales were US$22.
321 billion, an increase of 7.
9% year-on-year; net profit was US$6.
197 billion, an increase of 6.
9% year-on-year
.
By business, sales of the pharmaceutical business were US$12.
199 billion, a year-on-year increase of 9.
6%, of which the sales of new crown vaccines were US$100 million
.
Medical device business sales were US$6.
579 billion, a year-on-year increase of 10.
9%
.
Consumer health business sales were US$3.
543 billion, a year-on-year decrease of 2.
3%
.
BD announced its first quarter 2021 results
.
Quarterly revenue was US$4.
907 billion, an increase of 15.
4% from US$4.
253 billion in the same period last year; net profit was US$277 million, an increase of 90.
6% from US$145 million in the same period last year
.
.
Quarterly revenue was US$4.
907 billion, an increase of 15.
4% from US$4.
253 billion in the same period last year; net profit was US$277 million, an increase of 90.
6% from US$145 million in the same period last year
.
Siemens Healthineers (Siemens Healthineers) announced its results for the second quarter of fiscal year 2021 as of March 31
.
Quarterly revenue was 3.
965 billion euros (approximately US$4.
83 billion), compared with 3.
685 billion euros in the same period last year
.
Adjusted EBIT profit was 666 million euros, compared with 665 million euros in the same period last year
.
Net profit for the quarter was 447 million euros, compared with 414 million euros in the same period last year
.
.
Quarterly revenue was 3.
965 billion euros (approximately US$4.
83 billion), compared with 3.
685 billion euros in the same period last year
.
Adjusted EBIT profit was 666 million euros, compared with 665 million euros in the same period last year
.
Net profit for the quarter was 447 million euros, compared with 414 million euros in the same period last year
.
Roche announced its first quarter 2021 results
.
Group sales in the quarter were 14.
9 billion Swiss francs, compared with 15.
1 billion Swiss francs in the same period last year
.
Among them, sales in the pharmaceuticals department were 10.
6 billion Swiss francs, a year-on-year decrease of 14%; sales in the diagnostics department were 4.
3 billion Swiss francs (approximately US$4.
765 billion), a year-on-year increase of 50%
.
.
Group sales in the quarter were 14.
9 billion Swiss francs, compared with 15.
1 billion Swiss francs in the same period last year
.
Among them, sales in the pharmaceuticals department were 10.
6 billion Swiss francs, a year-on-year decrease of 14%; sales in the diagnostics department were 4.
3 billion Swiss francs (approximately US$4.
765 billion), a year-on-year increase of 50%
.
The financial report released by Philips shows that in the first quarter of 2021, sales were 3.
827 billion euros (approximately 4.
66 billion US dollars), an increase of 3.
6% year-on-year; net profit was 40 million euros, compared with 39 million euros in the same period last year
.
It has allocated 250 million euros to deal with risks related to quality problems detected in some of its respiratory health care equipment
.
In the first quarter, adjusted profit before interest, taxes and amortization (EBITA) soared 74% year-on-year to 362 million euros.
Comparable sales increased by 9%, far exceeding market expectations, as the new crown epidemic promoted its hospital equipment and The demand for personal health appliances
.
827 billion euros (approximately 4.
66 billion US dollars), an increase of 3.
6% year-on-year; net profit was 40 million euros, compared with 39 million euros in the same period last year
.
It has allocated 250 million euros to deal with risks related to quality problems detected in some of its respiratory health care equipment
.
In the first quarter, adjusted profit before interest, taxes and amortization (EBITA) soared 74% year-on-year to 362 million euros.
Comparable sales increased by 9%, far exceeding market expectations, as the new crown epidemic promoted its hospital equipment and The demand for personal health appliances
.
General Electric (GE) announced the first quarter of 2021 financial results
.
Quarterly revenue was 17.
118 billion U.
S.
dollars, compared with 19.
49 billion U.
S.
dollars in the same period last year
.
The quarterly net loss was US$2.
798 billion, and a net profit of US$6.
233 billion was recorded in the same period last year
.
The revenue of the industrial sector was US$16.
329 billion, a year-on-year decrease of 13%; the revenue of the capital sector was US$878 million, a year-on-year increase of 5%
.
Divided by specific business, medical business revenue was US$4.
309 billion, a year-on-year decrease of 9%
.
.
Quarterly revenue was 17.
118 billion U.
S.
dollars, compared with 19.
49 billion U.
S.
dollars in the same period last year
.
The quarterly net loss was US$2.
798 billion, and a net profit of US$6.
233 billion was recorded in the same period last year
.
The revenue of the industrial sector was US$16.
329 billion, a year-on-year decrease of 13%; the revenue of the capital sector was US$878 million, a year-on-year increase of 5%
.
Divided by specific business, medical business revenue was US$4.
309 billion, a year-on-year decrease of 9%
.
Stryker, a medical device and equipment manufacturer, announced its first quarter 2021 results
.
Quarterly net sales were US$3.
953 billion, an increase of 10.
2% from US$3.
588 billion in the same period last year; net profit was US$302 million, a decrease of 38.
7% from US$493 million in the same period last year
.
.
Quarterly net sales were US$3.
953 billion, an increase of 10.
2% from US$3.
588 billion in the same period last year; net profit was US$302 million, a decrease of 38.
7% from US$493 million in the same period last year
.
Baxter International Inc.
announced its first quarter 2021 results
.
Quarterly net sales were US$2.
946 billion, an increase of 5% from US$2.
802 billion in the same period last year; net profit was US$298 million, a decrease of 10% from US$332 million in the same period last year
.
announced its first quarter 2021 results
.
Quarterly net sales were US$2.
946 billion, an increase of 5% from US$2.
802 billion in the same period last year; net profit was US$298 million, a decrease of 10% from US$332 million in the same period last year
.
Henry Schein announced its first quarter 2021 results
.
Quarterly net sales were US$2.
925 billion, compared with US$2.
429 billion in the same period last year; net profit was US$166 million, compared with US$130 million in the same period last year
.
.
Quarterly net sales were US$2.
925 billion, compared with US$2.
429 billion in the same period last year; net profit was US$166 million, compared with US$130 million in the same period last year
.
Boston Scientific announced its first quarter 2021 results
.
Quarterly net sales were US$2.
752 billion, compared with US$2.
543 billion in the same period last year; net profit was US$327 million, compared with US$11 million in the same period last year
.
.
Quarterly net sales were US$2.
752 billion, compared with US$2.
543 billion in the same period last year; net profit was US$327 million, compared with US$11 million in the same period last year
.
Owens & Minor (Owens & Minor) announced the first quarter of 2021 results
.
Quarterly revenue was US$2.
327 billion, compared with US$2.
123 billion in the same period of the previous year; net profit was US$69.
59 million, and a net loss of US$11.
32 million in the same period last year
.
.
Quarterly revenue was US$2.
327 billion, compared with US$2.
123 billion in the same period of the previous year; net profit was US$69.
59 million, and a net loss of US$11.
32 million in the same period last year
.
3M Company announced the first quarter of 2021 results
.
Quarterly net sales of 8.
851 billion U.
S.
dollars, compared with 8.
075 billion U.
S.
dollars in the same period last year
.
The quarterly net profit was 1.
624 billion U.
S.
dollars, compared with 1.
308 billion U.
S.
dollars in the same period last year
.
Among them, the total sales of health care products are 2.
248 billion US dollars
.
.
Quarterly net sales of 8.
851 billion U.
S.
dollars, compared with 8.
075 billion U.
S.
dollars in the same period last year
.
The quarterly net profit was 1.
624 billion U.
S.
dollars, compared with 1.
308 billion U.
S.
dollars in the same period last year
.
Among them, the total sales of health care products are 2.
248 billion US dollars
.
Alcon (Alcon) announced the first quarter of 2021 results
.
Quarterly revenue was US$1.
93 billion, compared with US$1.
841 billion in the same period last year; net profit was US$84 million and a net loss of US$57 million in the same period last year
.
.
Quarterly revenue was US$1.
93 billion, compared with US$1.
841 billion in the same period last year; net profit was US$84 million and a net loss of US$57 million in the same period last year
.
Zimmer Biomet Holdings Inc.
announced its first quarter 2021 results
.
Quarterly net sales were US$1.
847 billion, compared to US$1.
784 billion in the same period last year; net profit was US$198 million and a net loss of US$508 million in the same period last year
.
announced its first quarter 2021 results
.
Quarterly net sales were US$1.
847 billion, compared to US$1.
784 billion in the same period last year; net profit was US$198 million and a net loss of US$508 million in the same period last year
.
Olympus (OLYMPUS) announced its fiscal year results (April 2020-March 2021)
.
Revenue in the fiscal year was 730.
5 billion yen (approximately US$6.
645 billion), compared with 755.
2 billion yen in the previous year
.
Operating profit for the fiscal year was 81.
985 billion yen, compared with 92.
2 billion yen in the previous fiscal year
.
Net profit for the fiscal year was 12.
918 billion yen, compared with 51.
67 billion yen in the previous fiscal year
.
Among them, the endoscope business revenue was 425.
742 billion yen, the treatment business revenue was 21.
075 billion yen, and the scientific business revenue was 105.
189 billion yen
.
.
Revenue in the fiscal year was 730.
5 billion yen (approximately US$6.
645 billion), compared with 755.
2 billion yen in the previous year
.
Operating profit for the fiscal year was 81.
985 billion yen, compared with 92.
2 billion yen in the previous fiscal year
.
Net profit for the fiscal year was 12.
918 billion yen, compared with 51.
67 billion yen in the previous fiscal year
.
Among them, the endoscope business revenue was 425.
742 billion yen, the treatment business revenue was 21.
075 billion yen, and the scientific business revenue was 105.
189 billion yen
.
Terumo announced its fiscal year results (April 2020-March 2021)
.
Fiscal year revenue was 613.
8 billion yen (approximately US$5.
583 billion), compared with 628.
9 billion yen in the previous year
.
Operating profit for the fiscal year was 98.
386 billion yen, compared with 110.
611 billion yen in the previous fiscal year
.
The net profit for the fiscal year was 77.
268 billion yen, compared with 85.
211 billion yen in the previous fiscal year
.
.
Fiscal year revenue was 613.
8 billion yen (approximately US$5.
583 billion), compared with 628.
9 billion yen in the previous year
.
Operating profit for the fiscal year was 98.
386 billion yen, compared with 110.
611 billion yen in the previous fiscal year
.
The net profit for the fiscal year was 77.
268 billion yen, compared with 85.
211 billion yen in the previous fiscal year
.
Smith & Nephew (Smith & Nephew) announced the first quarter of 2021 results
.
The quarterly total revenue was US$1.
264 billion, an increase of 11.
5% from US$1.
134 billion in the same period last year
.
.
The quarterly total revenue was US$1.
264 billion, an increase of 11.
5% from US$1.
134 billion in the same period last year
.
Canon Group (Canon) released its financial report for the first quarter of 2021
.
Group turnover increased by 7.
7% year-on-year to 842.
7 billion yen
.
The group's net profit was 44.
454 billion yen, a year-on-year increase of 102.
9%
.
Among them, the turnover of the medical business this quarter increased by 17.
3% compared with the same period last year, to 124.
4 billion yen (approximately 1.
13 billion US dollars)
.
.
Group turnover increased by 7.
7% year-on-year to 842.
7 billion yen
.
The group's net profit was 44.
454 billion yen, a year-on-year increase of 102.
9%
.
Among them, the turnover of the medical business this quarter increased by 17.
3% compared with the same period last year, to 124.
4 billion yen (approximately 1.
13 billion US dollars)
.
Mindray Medical released its first quarterly report for 2021.
The company achieved revenue of 5.
781 billion yuan (approximately US$906 million), a year-on-year increase of 21.
93%, and achieved a net profit of 1.
715 billion yuan attributable to the parent, a year-on-year increase of 30.
59%
.
( Global Corporate News )
The company achieved revenue of 5.
781 billion yuan (approximately US$906 million), a year-on-year increase of 21.
93%, and achieved a net profit of 1.
715 billion yuan attributable to the parent, a year-on-year increase of 30.
59%
.
( Global Corporate News )
